Sponsor content
194 result(s) found, displaying 41 to 50
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO KwikPen tirzepatide 12.5 mg/mL solution for injection multidose pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO KwikPen tirzepatide 8.33 mg/mL solution for injection multidose pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO KwikPen tirzepatide 20.83 mg/mL solution for injection multidose pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO KwikPen tirzepatide 25 mg/mL solution for injection multidose pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO KwikPen tirzepatide 16.67 mg/mL solution for injection multidose pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EBGLYSS lebrikizumab 250 mg/2 mL solution for injection autoinjector (pre-filled pen).
-
Australian Public Assessment Report (AusPAR)Ebglyss (lebrikizumab) was approved to treat severe atopic dermatitis in adult and adolescent patients.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMVOH mirikizumab 300 mg/15 mL (20 mg/mL) concentrated injection vial for IV infusion.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMVOH mirikizumab 100 mg/mL solution for injection autoinjector (pre-filled pen).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMVOH mirikizumab 100 mg/mL solution for injection pre-filled syringe.